TL;DR
This study explores the feasibility and utility of digital health tools (DHTs), specifically smartwatches and mobile apps, for monitoring individuals and families affected by Li-Fraumeni Syndrome (LFS). The findings suggest that DHTs can capture valuable psychological and physiological data, enabling timely detection of distress and facilitating targeted interventions, offering a promising avenue for personalized care in chronic disease management.
What Problem Does This Paper Address?
The paper addresses the challenge of integrating digital health tools (DHTs) into clinical settings, particularly for pediatric populations and families managing chronic conditions like Li-Fraumeni Syndrome (LFS). While DHTs offer potential for personalized care and real-time monitoring, their user engagement, clinical utility, and ability to capture meaningful data in these specific contexts remain unclear. LFS is a genetic condition that significantly increases cancer risk, necessitating lifelong surveillance and often leading to considerable psychological stress ("scanxiety") for affected individuals and their families. The study aims to evaluate how well DHTs can capture this distress and provide actionable insights for clinicians and patients.
Methods
The study employed an observational design, collecting longitudinal data from participants with LFS and their family members aged 5 and older. Key methods included:
- Smartwatch Monitoring: Participants wore an Empatica EmbracePlus smartwatch to collect physiological data such as electrodermal activity (EDA), heart rate, heart rate variability (HRV), and skin temperature.
- Mobile App Surveys: A dedicated mobile app (MyCap) administered daily, weekly, biweekly, and monthly surveys to assess psychosocial well-being, including depression (PHQ-9), sleep-related impairment (PROMIS SRI), perceived stress (PSS-4), and anxiety (GAD-7). For younger children, parents completed surveys on their behalf.
- Survival Analysis: Used to characterize engagement over time, analyzing survey completion rates and smartwatch wear duration.
- Generalized Additive Models (GAMs): Employed to explore physiological patterns in relation to cancer surveillance events, aiming to understand "scanxiety."
- Qualitative Feedback: Semistructured interviews and end-of-study questionnaires gathered insights into user experiences, preferences, and challenges.
Datasets
The study utilized data from three sources:
- Epic Electronic Health Record: Provided baseline clinical information, including patient demographics.
- Empatica Smartwatch Data: Collected physiological data streams.
- MyCap Study App Data: Captured survey responses.
No new benchmarks were introduced; the study focused on evaluating existing DHTs within a specific clinical context.
Key Insights and Ideas
- Feasibility in High-Risk Populations: DHTs are feasible for capturing clinically meaningful psychological and physiological data in pediatric and family populations affected by LFS.
- Timely Distress Detection: The study demonstrated that DHTs can enable the timely detection of psychological distress, such as increased anxiety and depression, particularly in children.
- "Scanxiety" Monitoring: Physiological data from smartwatches showed potential for modeling iatrogenic effects like "scanxiety" (stress and anxiety related to surveillance scans).
- Individualized Physiological Responses: GAM analysis revealed significant inter- and intra-individual heterogeneity in physiological responses to clinical surveillance, highlighting the need for personalized monitoring.
- Importance of User Experience: Qualitative feedback underscored the critical role of device comfort, functionality, and aesthetics in sustaining engagement, especially for long-term use.
Key Results
- Engagement: Adults wore smartwatches more often than children (81% vs. 56%). Survey engagement was high across all groups (over 50% completion).
- Psychosocial Burden in Children: Children reported significantly higher levels of depressive symptoms (PHQ-9 scores) and sleep-related impairment (PROMIS SRI) compared to adults. They also reported being "very stressed" more frequently.
- Critical Event Detection: A suicide alert system, triggered by the PHQ-9 survey, successfully identified 5 participants (11%) and prompted timely clinical intervention.
- Retention: Median smartwatch retention was significantly longer for adults (153 days) than for children (77 days).
- Qualitative Feedback: Participants found value in stress awareness but noted challenges with device comfort and functionality.
Limitations and Future Work
- Sample Size and Generalizability: The study had a small sample size and focused on a niche patient population (LFS), which may limit generalizability to broader populations.
- Engagement Gap in Children: While children experienced higher distress, their engagement with DHTs was lower, presenting a challenge for future interventions.
- Device Limitations: The research-grade smartwatch lacked consumer features like messaging, which some participants felt made it a constant reminder of their disease.
- Future Work: The authors suggest future research should focus on:
- Better understanding and addressing the engagement gap in children.
- Selecting DHTs that seamlessly integrate into daily life.
- Exploring physiological signatures of clinical surveillance to develop early warning systems.
- Integrating DHT data into clinician dashboards for real-time monitoring.
- Larger studies to optimize DHT application and address potential challenges.
Summary updated